Literature DB >> 24165999

Reproductive endocrinology: Hormone therapy to treat menopause--breaking a taboo.

Susan R Davis1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24165999     DOI： 10.1038/nrendo.2013.219

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Using longitudinal profiles to characterize women's symptoms through midlife: results from a large prospective study.

Authors:  Gita D Mishra; Annette J Dobson
Journal:  Menopause       Date:  2012-05       Impact factor: 2.953

2.  The impact of menopausal symptoms on work ability.

Authors:  Marije Geukes; Mariëlle P van Aalst; Mary C E Nauta; Henk Oosterhof
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

3.  Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.

Authors:  Dale W Stovall; Kirby Tanner-Kurtz; JoAnn V Pinkerton
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

4.  Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

Authors:  T J de Villiers; A Pines; N Panay; M Gambacciani; D F Archer; R J Baber; S R Davis; A A Gompel; V W Henderson; R Langer; R A Lobo; G Plu-Bureau; D W Sturdee
Journal:  Climacteric       Date:  2013-06       Impact factor: 3.005

Review 5.  Understanding weight gain at menopause.

Authors:  S R Davis; C Castelo-Branco; P Chedraui; M A Lumsden; R E Nappi; D Shah; P Villaseca
Journal:  Climacteric       Date:  2012-10       Impact factor: 3.005

6.  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.

Authors:  Gillian K Reeves; Kirstin Pirie; Valerie Beral; Jane Green; Elizabeth Spencer; Diana Bull
Journal:  BMJ       Date:  2007-11-06

7.  A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer.

Authors:  Barbara S Connolly; Carmen Barnett; Kelly N Vogt; Tong Li; Jennifer Stone; Norman F Boyd
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

Review 8.  Where are we 10 years after the Women's Health Initiative?

Authors:  Roger A Lobo
Journal:  J Clin Endocrinol Metab       Date:  2013-03-14       Impact factor: 5.958

9.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

10.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Authors:  JoAnn E Manson; Rowan T Chlebowski; Marcia L Stefanick; Aaron K Aragaki; Jacques E Rossouw; Ross L Prentice; Garnet Anderson; Barbara V Howard; Cynthia A Thomson; Andrea Z LaCroix; Jean Wactawski-Wende; Rebecca D Jackson; Marian Limacher; Karen L Margolis; Sylvia Wassertheil-Smoller; Shirley A Beresford; Jane A Cauley; Charles B Eaton; Margery Gass; Judith Hsia; Karen C Johnson; Charles Kooperberg; Lewis H Kuller; Cora E Lewis; Simin Liu; Lisa W Martin; Judith K Ockene; Mary Jo O'Sullivan; Lynda H Powell; Michael S Simon; Linda Van Horn; Mara Z Vitolins; Robert B Wallace
Journal:  JAMA       Date:  2013-10-02       Impact factor: 56.272
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.